Innovent Biologics, Inc. (HKG:1801)
96.40
+2.80 (2.99%)
Sep 30, 2025, 4:08 PM HKT
Innovent Biologics Employees
Innovent Biologics had 5,659 employees as of December 31, 2024. The number of employees increased by 787 or 16.15% compared to the previous year.
Employees
5,659
Change (1Y)
787
Growth (1Y)
16.15%
Revenue / Employee
2.02M HKD
Profits / Employee
200.45K HKD
Market Cap
165.11B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5,659 | 787 | 16.15% |
Dec 31, 2023 | 4,872 | -422 | -7.97% |
Dec 31, 2022 | 5,294 | -274 | -4.92% |
Dec 31, 2021 | 5,568 | 2,289 | 69.81% |
Dec 31, 2020 | 3,279 | 1,297 | 65.44% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
BeOne Medicines AG | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Sino Biopharmaceutical | 24,379 |
Akeso | 3,035 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
CSPC Pharmaceutical Group | 21,400 |
Innovent Biologics News
- 8 days ago - Innovent's weight-loss drug highlights China challenge for Novo, Lilly - Reuters
- 11 days ago - Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 Diabetes - PRNewsWire
- 12 days ago - Innovent's Partner Ollin Announces Clinical Updates on IBI324 (OLN324, VEGF/ANG-2) - PRNewsWire
- 15 days ago - Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the 34th EADV Congress 2025 - PRNewsWire
- 20 days ago - Fangzhou and Innovent Biologics Form Strategic Alliance for AI-Powered Weight Management Solutions - GlobeNewsWire
- 22 days ago - Innovent Announces Phase 2 Results of Tigulixostat (IBI128, XOI) in Gout Patients were ... - GuruFocus
- 23 days ago - Innovent Announces Phase 2 Results of Tigulixostat (IBI128, XOI) in Gout Patients were Published at the 27th Asia-Pacific League of Associations for Rheumatology Congress - PRNewsWire
- 4 weeks ago - Innovent Biologics estimates ~50% jump in 2025 revenue - Seeking Alpha